Vesicular Stomatitis Virus-Based Vaccines against Lassa and Ebola Viruses

被引：137
|
作者：
Marzi, Andrea [1 ]
Feldmann, Friederike [1 ]
Geisbert, Thomas W. [2 ]
Feldmann, Heinz [1 ]
Safronetz, David [1 ]
机构：
[1] NIH, Hamilton, MT 59840 USA
[2] Univ Texas Med Branch, Galveston, TX 77555 USA
来源：
EMERGING INFECTIOUS DISEASES | 2015年 / 21卷 / 02期
基金：
美国国家卫生研究院;
关键词：
PROTECTS NONHUMAN-PRIMATES; ANTIBODIES; GLYCOPROTEINS; CHALLENGE; DISEASE;
D O I：
10.3201/eid2102.141649
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
We demonstrated that previous vaccination with a vesicular stomatitis virus (VSV) based Lassa virus vaccine does not alter protective efficacy of subsequent vaccination with a VSV-based Ebola virus vaccine. These findings demonstrate the utility of VSV-based vaccines against divergent viral pathogens, even when preexisting immunity to the vaccine vector is present.
引用
收藏
页码：305 / 307
页数：3
相关论文
共 50 条
  • [1] Recombinant Vesicular Stomatitis Virus-Based Vaccines Against Ebola and Marburg Virus Infections
    Geisbert, Thomas W.
    Feldmann, Heinz
    JOURNAL OF INFECTIOUS DISEASES, 2011, 204 : S1075 - S1081
  • [2] Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses
    Geisbert, Thomas W.
    Daddario-DiCaprio, Kathleen M.
    Geisbert, Joan B.
    Reed, Douglas S.
    Feldmann, Friederike
    Grolla, Allen
    Stroeher, Ute
    Fritz, Elizabeth A.
    Hensley, Lisa E.
    Jones, Steven M.
    Feldmann, Heinz
    VACCINE, 2008, 26 (52) : 6894 - 6900
  • [3] Safety and immunogenicity of vesicular stomatitis virus-based vaccines for Ebola virus disease
    de La Vega, Marc-Antoine
    Kobinger, Gary P.
    LANCET INFECTIOUS DISEASES, 2020, 20 (04): : 388 - 389
  • [4] Vesicular Stomatitis Virus-Based Ebola Vaccines With Improved Cross-Protective Efficacy
    Marzi, Andrea
    Ebihara, Hideki
    Callison, Julie
    Groseth, Allison
    Williams, Kinola J.
    Geisbert, Thomas W.
    Feldmann, Heinz
    JOURNAL OF INFECTIOUS DISEASES, 2011, 204 : S1066 - S1074
  • [5] Vesicular Stomatitis Virus-Based Vaccines Provide Cross-Protection against Andes and Sin Nombre Viruses
    Warner, Bryce M.
    Stein, Derek R.
    Jangra, Rohit K.
    Slough, Megan M.
    Sroga, Patrycja
    Sloan, Angela
    Frost, Kathy L.
    Booth, Stephanie
    Chandran, Kartik
    Safronetz, David
    VIRUSES-BASEL, 2019, 11 (07):
  • [6] A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
    Safronetz, David
    Mire, Chad
    Rosenke, Kyle
    Feldmann, Friederike
    Haddock, Elaine
    Geisbert, Thomas
    Feldmann, Heinz
    PLOS NEGLECTED TROPICAL DISEASES, 2015, 9 (04):
  • [7] Evaluating Temperature Sensitivity of Vesicular Stomatitis Virus-Based Vaccines
    Stein, Derek R.
    Sroga, Patrycja
    Warner, Bryce M.
    Deschambault, Yvon
    Poliquin, Guillaume
    Safronetz, David
    EMERGING INFECTIOUS DISEASES, 2019, 25 (08) : 1563 - 1566
  • [8] Vesicular Stomatitis Virus-Based Vaccines Protect Nonhuman Primates against Bundibugyo ebolavirus
    Mire, Chad E.
    Geisbert, Joan B.
    Marzi, Andrea
    Agans, Krystle N.
    Feldmann, Heinz
    Geisbert, Thomas W.
    PLOS NEGLECTED TROPICAL DISEASES, 2013, 7 (12):
  • [9] The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
    Suder, Ellen
    Furuyama, Wakako
    Feldmann, Heinz
    Marzi, Andrea
    de Wit, Emmie
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (09) : 2107 - 2113
  • [10] Protective Efficacy of Lyophilized Vesicular Stomatitis Virus-Based Vaccines in Animal Model
    Salawudeen, Abd'jeleel
    Soule, Geoff
    Tailor, Nikesh
    Klassen, Levi
    Audet, Jonathan
    Sloan, Angela
    Deschambault, Yvon
    Safronetz, David
    EMERGING INFECTIOUS DISEASES, 2024, 30 (05) : 1004 - 1008
12345